Austin W. Marxe & David M. Greenhouse’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Austin W. Marxe & David M. Greenhouse’s Portfolio MRNS Stock Details MRNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$1.73M	Buy	+66,834	New	+$2.06M	0.24%	93

Other funds holding MRNS

CPV

Canaan Partners VII Westport, Connecticut $32.3M AUM 154.97% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Austin W. Marxe & David M. Greenhouse's MRNS Position: Q3 2014 in Review

Austin W. Marxe & David M. Greenhouse opened a new position in Marinus Pharmaceuticals, Inc (MRNS) in Q3 2014: 66,834 shares worth $1.73M. The stake represents 0.24% of the portfolio and ranks #93 among its holdings.

18 funds tracked by Wall St. Rank hold MRNS as of Q3 2014.

Austin W. Marxe & David M. Greenhouse held 66,834 shares of Marinus Pharmaceuticals, Inc worth $1.73M as of Q3 2014.
Marinus Pharmaceuticals, Inc was a new Austin W. Marxe & David M. Greenhouse position in Q3 2014.
Marinus Pharmaceuticals, Inc made up 0.24% of Austin W. Marxe & David M. Greenhouse's portfolio in Q3 2014, its #93 holding.
18 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q3 2014.

Based on Austin W. Marxe & David M. Greenhouse's 13F filing for Q3 2014, filed 14 Nov 2014.